» Articles » PMID: 32699335

Recombinant Expression, Purification and PEGylation of Paneth Cell Peptide (cryptdin-2) with Value Added Attributes Against Staphylococcus Aureus

Overview
Journal Sci Rep
Specialty Science
Date 2020 Jul 24
PMID 32699335
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Cryptdins are disulfide-rich cationic antimicrobial peptides secreted by mouse Paneth cells and are known to exhibit potent antimicrobial activity against various deadly pathogens. Keeping in view the extremely low yield obtained from mouse Paneth cells and high cost of synthetic peptide(s), herein, we have attempted to produce cryptdin-2 in Escherichia coli using recombinant technology. To avoid lethal effects of peptide on the host cells, cryptdin-2 was expressed as a fusion protein with thioredoxin as fusion partner which yielded 40 mg/L protein in the soluble fraction. Subsequently, mature cryptdin-2 was cleaved from the fusion partner and purified by cation exchange chromatography. Since conjugation of poly(ethylene) glycol (PEG) has been known to improve the biological properties of biomolecules, therefore, we further attempted to prepare PEG-conjugated variant of cryptdin-2 using thiol specific PEGylation. Though the antimicrobial activity of PEGylated cryptdin-2 was compromised to some extent, but it was found to have enhanced serum stability for longer duration as compared to its un-modified forms. Also, it was found to exhibit reduced toxicity to the host cells. Further, its synergism with gentamicin suggests that PEGylated cryptdin-2 can be used with conventional antibiotics, thereby indicating its possibility to be used as an adjunct therapy.

Citing Articles

Revolutionizing orthopedic healthcare: a systematic review unveiling recombinant antimicrobial peptides.

Pennone V, Rosini E, Mascheroni E, Gianola S, Castellini G, Bargeri S Front Microbiol. 2024; 15:1370826.

PMID: 38756724 PMC: 11097975. DOI: 10.3389/fmicb.2024.1370826.


Antimicrobial Peptide-Poly(ethylene glycol) Conjugates: Connecting Molecular Architecture, Solution Properties, and Functional Performance.

Cui Z, Crawford M, Rumble B, Krogh M, Hughes M, Letteri R ACS Polym Au. 2024; 4(1):45-55.

PMID: 38371733 PMC: 10870750. DOI: 10.1021/acspolymersau.3c00026.


Going Beyond Host Defence Peptides: Horizons of Chemically Engineered Peptides for Multidrug-Resistant Bacteria.

Cavallazzi Sebold B, Li J, Ni G, Fu Q, Li H, Liu X BioDrugs. 2023; 37(5):607-623.

PMID: 37300748 PMC: 10432368. DOI: 10.1007/s40259-023-00608-3.


The future of recombinant host defense peptides.

Roca-Pinilla R, Lisowski L, Aris A, Garcia-Fruitos E Microb Cell Fact. 2022; 21(1):267.

PMID: 36544150 PMC: 9768982. DOI: 10.1186/s12934-022-01991-2.


The dual interaction of antimicrobial peptides on bacteria and cancer cells; mechanism of action and therapeutic strategies of nanostructures.

Parchebafi A, Tamanaee F, Ehteram H, Ahmad E, Nikzad H, Haddad Kashani H Microb Cell Fact. 2022; 21(1):118.

PMID: 35717207 PMC: 9206340. DOI: 10.1186/s12934-022-01848-8.


References
1.
Ganz T . Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol. 2003; 3(9):710-20. DOI: 10.1038/nri1180. View

2.
Jing W, Hunter H, Tanabe H, Ouellette A, Vogel H . Solution structure of cryptdin-4, a mouse paneth cell alpha-defensin. Biochemistry. 2004; 43(50):15759-66. DOI: 10.1021/bi048645p. View

3.
Selsted M, Ouellette A . Mammalian defensins in the antimicrobial immune response. Nat Immunol. 2005; 6(6):551-7. DOI: 10.1038/ni1206. View

4.
Szyk A, Wu Z, Tucker K, Yang D, Lu W, Lubkowski J . Crystal structures of human alpha-defensins HNP4, HD5, and HD6. Protein Sci. 2006; 15(12):2749-60. PMC: 2242434. DOI: 10.1110/ps.062336606. View

5.
Pazgier M, Li X, Lu W, Lubkowski J . Human defensins: synthesis and structural properties. Curr Pharm Des. 2007; 13(30):3096-118. DOI: 10.2174/138161207782110381. View